Text Registration
Copyright Title
Insulin Resistance and Cancer, Editor I. George Fantus
Status
Published
on 31 Aug 2011
Year of Creation
2011
Copyright Claimant
Springer Science+Business Media, LLC
Registration Number
TX0007431241
on 31 Aug 2011Copyright Summary
The U.S. Copyright record (Registration Number: TX0007431241) dated 31 Aug 2011, pertains to an electronic file (eService) titled "Insulin Resistance and Cancer, Editor I. George Fantus" created in 2011. The copyright holder is Springer Science+Business Media, LLC, known for their creative contributions in text registration. For any inquiries concerning this copyrighted material, kindly reach out to Springer Science+Business Media, LLC.
Application Details
Registration Number
TX0007431241
Registration Date
8/31/2011
Year of Creation
2011
Agency Marc Code
DLC-CO
Record Status
New
Corporate Author
Springer Science+Business Media, LLC
Physical Description
Book, 298 p
First Publication Nation
United States
ISBN
978-1-4419-9910-8
Notes
Local Copyright Note: Regarding deposit: work deposited is a collective work
Statements
Application Title Statement: Insulin Resistance and Cancer, Editor I. George Fantus
Author Statement: Springer Science+Business Media, LLC employer for hire Domicile: not known Citizenship: not known Authorship: text, editing
© 2024 reserved by Trademarkia
Show terms & conditions
Disclaimer: The information contained in this website is provided for informational purposes only, and should not be construed as legal advice. Although LegalForce RAPC Worldwide P.C., dba Trademarkia P.C., is a law firm (the “Firm”), your use of this website does not establish an attorney-client relationship with the Firm. Such a relationship can only be established after the Firm decides that it is willing and able to accept the engagement after a conflict check and after a written retainer agreement is agreed upon between you and the Firm. Your use of this website is also subject to our Terms of Use and Privacy Policy. ** The entry level subscription is a bundled price which requires a minimum of two billing cycles, or 6 months.